middle.news

BCAL opens path to revived Genetic Signatures and Microba merger

2:39pm on Thursday 19th of November, 2026 AEDT • Healthcare
Read Story

BCAL opens path to revived Genetic Signatures and Microba merger

2:39pm on Thursday 19th of November, 2026 AEDT
Key Points
  • 60:40 merger ratio in favour of Genetic Signatures
  • Fiduciary out requested for a superior GSS proposal
  • Up to $2 million of conditional Microba funding
  • Support tied to GSS board restructure and chair resignation
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Bcal Diagnostics (ASX:BDX)
OPEN ARTICLE